1 completed, 1 enrolling by invitation, 1 recruiting. 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Recruiting 1 |
| Phase 3 | 1 | Completed 1 |
Follow Complement Component 3 Deficiency, Autosomal Recessive: new trials by email Literature Review of Complement Component 3 Deficiency, Autosomal Recessive trials Research Report on Complement Component 3 Deficiency, Autosomal Recessive
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase 2 Study to Evaluate the Safety, PD, PK, and Clinical Activity of ADX-097 in Participants With IgAN, LN or C3G ADX-097 - IgA Nephropathy, Lupus Nephritis (LN) | Phase 2 | Recruiting | Akebia Therapeutics | 30 | 2026-07-30 | 2026-10-01 |
| Immune System in Diabetic Kidney Disease Diabetes, Diabetic Kidney Disease | Enrolling by invitation | University Medical Centre Ljubljana | 90 | 2025-12-01 | 2026-02-23 | |
| The De-novo Use of Eculizumab in Presensitized Patients Receiving Cardiac Transplantation Eculizumab - Antibody-mediated Rejection, Hyperacute Rejection of Cardiac Transplant | Phase 3 | Completed | Cedars-Sinai Medical Center | 36 | 2012-11-01 | 2021-05-03 |
Diabetes Mellitus (1) · Diabetic Nephropathies (1) · Glomerulonephritis, IGA (1) · Lupus Nephritis (1) · Ventricular Dysfunction, Left (1)
Female Urogenital Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2) · Kidney Diseases (2) · Male Urogenital Diseases (2) · Urogenital Diseases (2) · Urologic Diseases (2) · Autoimmune Diseases (1) · Cardiovascular Diseases (1) · Connective Tissue Diseases (1) · Diabetes Complications (1) · Endocrine System Diseases (1) · Glomerulonephritis (1) · Glucose Metabolism Disorders (1) · Heart Diseases (1) · Immune System Diseases (1)
eculizumab (1)
Akebia Therapeutics (1) · Cedars-Sinai Medical Center (1) · University Medical Centre Ljubljana (1)
United States (2) · Brazil (1) · Slovenia (1)
Jignesh Patel, M.D., Ph.D. (1)